About Us
Meet Dr. Keith
Meet Dr. Keith A. Moskowitz
Research & Product Development Leadership ~ Program & Project Management ~ Strategic Intellectual Property Innovation ~ Medical, Scientific & Clinical Affairs ~ Business Development
Seasoned executive professional with 30 years of progressively responsible experience directing R&D through start-up, survival, turnaround, and growth phases. Expertise in technical, management, and liaison roles across hemostasis and thrombosis (recognized as a Key Opinion Leader), immunology, wound healing, infectious and genetic diseases, and oncology. Industry experience spans central laboratory and point-of-care diagnostics, medical devices, biologicals, custom laboratory services, and biotechnology.
Proven track record in leadership, talent management, and innovation, with demonstrated success in bringing numerous products and services from concept to market and through post-market growth. Achievements include 18 issued and 21 pending patents, over 50 peer-reviewed publications and abstracts, a half dozen 510(k)-cleared diagnostics, two cleared interventional medical devices, two successful biological IND submissions, and two biopharma co-development deals with total value generation exceeding $100 million.
Honored to be serving as a peer reviewer for the medical journal Transfusion.
Recently appointed as a Consultant with #CrystalDiagnostics, contributing to the advancement of Accupath™ and Accupath™ MAX technologies for rapid detection of foodborne pathogens. This work supports improvements in the speed, accuracy, and accessibility of pathogen detection—critical to strengthening food safety systems, protecting public health, and enabling more effective responses to contamination risks.
Crystal Diagnostics is developing innovative solutions to enhance pathogen identification across the food supply chain, from production through quality control testing. Through this role, contributes to the strategic development and advancement of technologies aimed at making global food systems safer.
Our Mission
At KA BIOSCIENCE CONSULTANTS, LLC, we partner with companies to drive advancements in biosciences. We support innovation from ideation through commercialization, ensuring scientific rigor, regulatory compliance, and market success.
Innovations in Bioscience & Healthcare
Our products reflect years of dedicated research and development, offering solutions in diagnostics, medical devices, and biopharmaceuticals. These innovations have been designed to enhance patient outcomes, streamline medical processes, and provide accurate and reliable data for healthcare professionals.
Proven Industry Expertise
With 25+ years of experience in bioscience R&D, Dr. Moskowitz has successfully led product development from concept to market, securing multiple FDA clearances and patents.
Innovative Problem-Solving
A recognized Key Opinion Leader in hemostasis and thrombosis, he brings strategic insight and scientific excellence to drive breakthroughs in diagnostics, medical devices, and biologics.
Results-Driven Success
His leadership has generated over $100M in value through biopharma co-development deals, ensuring that projects achieve both scientific and commercial success.
Collaborations
KA Bioscience Consultants + Maven Corp.
KA Bioscience Consultants and Maven Corp., led by Jeanne M. Novak, Ph.D., have joined forces to provide integrated development support for biotechnology, pharmaceutical, medical device, and diagnostics companies.
By combining Maven Corp.’s deep expertise in regulatory affairs, clinical development, quality systems, and FDA strategy with KA Bioscience Consultants’ scientific, technical, product development, program management, business development, and commercialization capabilities, our teams provide clients with a coordinated resource across the development lifecycle.
Combined Expertise
Scientific & Product Development
Preclinical Strategy
Clinical Development
Regulatory & FDA Strategy
Quality Systems
Program Management
Business Development
Commercialization Strategy
Corporate Advisory
Deep Regulatory and Development Experience
Dr. Jeanne M. Novak brings more than 25 years of product development and regulatory experience, including roles as a Senior Scientific Reviewer at FDA/CBER, advisor to the Center Director, and Regulatory Scientist at FDA/CDRH.
She later founded and led CBR International, a global strategic consulting organization supporting product, clinical, quality, and regulatory development. CBR International was acquired by Novotech CRO in 2023.
Together, KA Bioscience Consultants and Maven Corp. offer emerging and established life sciences companies an integrated approach designed to reduce development risk, accelerate timelines, efficiently deploy capital, and create a clear path toward regulatory and commercial success.
One team. One integrated strategy. From concept to commercialization.
Supporting the next generation of drugs, biologics, medical devices, diagnostics, and innovative healthcare technologies.
Meet Our Team
Jenie Villarta
Executive Virtual Assistant
Katie Burke
Company Bookkeeper
Why work with me
With decades of hands-on experience in bioscience innovation, I bring a deep understanding of the complexities of research, product development, and regulatory approval. My unique ability to bridge the gap between scientific discovery and commercialization makes me a valuable partner for companies seeking to navigate the competitive landscape of healthcare and biotechnology.
